false
0002079720
0002079720
2026-05-13
2026-05-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): May 13, 2026
Buda
Juice, Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-43043 |
|
46-4069365 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File Number) |
|
(I.R.S.
Employer
Identification
No.) |
4030
Black Gold Drive,
Dallas,
Texas 75247
(Address
of principal executive offices)
Registrant’s
telephone number, including area code: (214) 308-5003
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.001 par value |
|
BUDA |
|
NYSE
American LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
2.02 Results of Operations and Financial Condition
On
May 13, 2026, Buda Juice, Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2026. A copy
of the press release issued by the Company in this connection is furnished herewith as Exhibit 99.1.
The
information in this Item in this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed
“filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended or the Exchange Act, regardless of any general incorporation language in such filing.
Item
9.01 Financial Statement and Exhibits
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 99.1 |
|
Press Release dated May 13, 2026, issued by the Buda Juice, Inc. |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Date:
May 15, 2026 |
Buda
Juice, Inc. |
| |
|
|
| |
By: |
/s/
Horatio Lonsdale-Hands |
| |
Name: |
Horatio
Lonsdale-Hands |
| |
Title: |
Chief
Executive Officer |
Exhibit 99.1
Buda
Juice Reports First Quarter Fiscal 2026 Financial Results
Completes
First Full Quarter as a Public Company With 17.7% Revenue Growth and 37% Free Cash Flow Growth
Dallas,
TX, May 13, 2026 – Buda Juice, Inc. (NYSE American: BUDA), $BUDA, creator and pioneer of the Ultra Fresh™ category
in the supermarket fresh perimeter, today reported financial results for the quarter ended March 31, 2026.
Horatio
Lonsdale-Hands, Co-Founder and Chief Executive Officer of Buda Juice, commented:
“The
first quarter of fiscal 2026 represents a meaningful milestone for Buda Juice. It was effectively our first full quarter as a public
company, and we delivered on our commitments. Revenue grew nearly 18% year over year, above the mid-teens outlook we discussed on our
last earnings call, while free cash flow increased 37% from the prior-year period.
“Gross
margin was impacted by a temporary spike in lime costs following supply chain disruptions in western Mexico in March. Improved labor
efficiency, with labor costs as a percentage of revenue improving more than 150 basis points year over year, helped partially offset
the impact. Conditions stabilized by the end of the quarter, and we do not currently view this as reflective of the underlying economics
of our business.
“Subsequent
to quarter’s end, Buda Juice reached another major milestone with the expansion of Buda Fresh™ Cherry Limeade into 246 Walmart
stores across nine states. This significantly expanded our geographic footprint beyond Texas and represents an important early step in
demonstrating that the Ultra Fresh category and our Fresh35°™ cold-chain platform can scale into broader multi-state distribution.
“When
we went public in January, we stated that expanding distribution and bringing our products to more consumers would be a key next step
for the Company. We believe this expansion reflects continued progress against that strategy.”
First
Quarter Financial Highlights (2026 vs. 2025)
| |
● |
Revenue
increased 17.7% to $3.5 million compared to $3.0 million; |
| |
● |
Gross
Profit increased 3.5% to $1.4 million compared to $1.3 million; |
| |
● |
Operating
Income decreased to $0.6 million compared to $0.8 million; |
| |
● |
Net
Income of $0.4 million compared to $0.8 million; |
| |
● |
Diluted
earnings per share (EPS) of $0.03; |
| |
● |
Non-GAAP
Net Income of $0.6 million compared to $0.6 million; |
| |
● |
Non-GAAP
EPS of $0.05; |
| |
● |
Adjusted
EBITDA of $0.8 million; |
| |
● |
Free
Cash Flow of $1.1 million. |
1See
GAAP to Non-GAAP reconciliations at the end of this release
Conference
Call and Webcast Information
Buda
Juice will host a conference call this morning, at 11:00 a.m. Eastern Time to discuss its financial and operational results for its
first quarter ended March 31, 2026.
Dial-in
and Webcast Information
| Date/Time: |
|
Wednesday,
May 13, 2026, at 11:00 a.m. Eastern Time |
| Toll-Free
(North America): |
|
(800)
715-9871 |
| Toll/International: |
|
(646)
307-1963 |
| Conference
Call ID: |
|
7817249 |
| Webcast
Link: |
|
https://events.q4inc.com/attendee/605302226 |
Replay
Information
| Toll-Free
(North America) |
|
(800)
770-2030 |
| Toll/International: |
|
(609)
800-9909 |
| Conference
Call ID: |
|
7817249 |
| Expiration: |
|
Wednesday,
May 20, 2026, 11:59 p.m. Eastern Time |
About
Buda Juice
Buda
Juice (NYSE American: BUDA) is the creator and pioneer of the Ultra Fresh™ category through an end-to-end cold chain platform that
delivers always-cold, freshly crafted juices, lemonades and wellness shots to grocery retailers. The Company provides a turnkey alternative
to shelf-stable beverages and in-store juicing, enabling retailers to offer truly fresh, clean-label products without added infrastructure
or operational complexity. Its continuous 35°F cold chain from fruit to shelf delivers products with an 8 to 12-day shelf life that
preserves authentic taste and nutrient quality while enabling efficient retail distribution.
Buda
Juice’s proprietary cold-chain infrastructure enables the Company to scale the Ultra Fresh category nationally while maintaining
the quality, safety and consistency required by leading grocery retailers, with a disciplined focus on profitability. Additional information
about the Company can be found at https://budajuice.com.
Forward-Looking
Statements
This
press release contains certain “forward-looking statements”. These forward-looking statements involve known and unknown risks
and uncertainties and are based on the Company’s current expectations and projections about future events. Investors can find many
(but not all) of these statements by the use of words such as “may,” “will,” “expect,” “anticipate,”
“estimate,” “intend,” “plan,” “believe,” or other similar expressions. The Company undertakes
no obligation to update or revise publicly any forward-looking statements to reflect subsequent events or circumstances, except as may
be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable,
it cannot assure investors that such expectations will turn out to be correct, and the Company cautions that actual results may differ
materially from anticipated results. Additional factors are discussed in the Company’s public filings with the Securities and Exchange
Commission, available for review at www.sec.gov.
Buda
Juice Investor/Press Contact
Brian
S. Siegel, IRC®, M.B.A.
Senior
Managing Director
Hayden
IR – Chicago
(346)
396-8696 (o)
brian@haydenir.com
Buda
Juice LLC
Balance
Sheets
(Amounts
in Thousands)
| | |
As of | | |
As of | |
| | |
March 31, 2026 | | |
December 31, 2025 | |
| | |
(Unaudited) | | |
| |
| ASSETS | |
| | | |
| | |
| Current assets | |
| | | |
| | |
| Cash | |
$ | 19,828 | | |
$ | 1,840 | |
| Accounts receivable | |
| 494 | | |
| 386 | |
| Inventory | |
| 445 | | |
| 348 | |
| Prepaid expenses and other current assets | |
| 216 | | |
| 645 | |
| Total current assets | |
| 20,983 | | |
| 3,219 | |
| | |
| | | |
| | |
| Property and equipment, net of accumulated depreciation of $2,153 and $2,096, respectively | |
| 1,138 | | |
| 976 | |
| Operating lease right-of-use asset | |
| 739 | | |
| 775 | |
| Total assets | |
$ | 22,860 | | |
$ | 4,970 | |
| | |
| | | |
| | |
| LIABILITIES AND STOCKHOLDERS’ AND MEMBERS’ EQUITY | |
| | | |
| | |
| Current liabilities: | |
| | | |
| | |
| Accounts payable | |
$ | 623 | | |
$ | 289 | |
| Other current liabilities | |
| 279 | | |
| 161 | |
| Operating lease liability, current portion | |
| 139 | | |
| 135 | |
| Total current liabilities | |
| 1,041 | | |
| 585 | |
| | |
| | | |
| | |
| Operating lease liability, net of current portion | |
| 610 | | |
| 647 | |
| Deferred income tax liability | |
| 182 | | |
| - | |
| Total long-term liabilities | |
| 792 | | |
| 647 | |
| Total liabilities | |
| 1,833 | | |
| 1,232 | |
| Stockholders’ and Members’ Equity | |
| | | |
| | |
| Members’ equity | |
| - | | |
| 2,554 | |
| Preferred Stock, $0.001 par value; 10,000 shares authorized; 0 shares issued; 0 shares outstanding | |
| - | | |
| - | |
| Common stock, $0.001 par value — 90,000 shares authorized; 13,067 shares issued; 12,567 shares outstanding | |
| 13 | | |
| - | |
| Additional paid-in capital | |
| 23,192 | | |
| - | |
| Less: Treasury stock | |
| (3,750 | ) | |
| - | |
| Retained earnings | |
| 1,572 | | |
| 1,184 | |
| Total stockholders’ and members’ equity | |
| 21,027 | | |
| 3,738 | |
| Total liabilities and stockholders’ and members’ equity | |
$ | 22,860 | | |
$ | 4,970 | |
Buda
Juice LLC
Statements
of Operations
(Amounts
in Thousands, Except Per Share Data)
| | |
Three Months Ended March 31 | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Net sales | |
$ | 3,508 | | |
$ | 2,980 | |
| Cost of goods sold | |
| 2,122 | | |
| 1,642 | |
| Gross profit | |
| 1,386 | | |
| 1,338 | |
| | |
| | | |
| | |
| Operating expenses: | |
| | | |
| | |
| Delivery and handling expense | |
| 130 | | |
| 128 | |
| Selling, general and administrative expense | |
| 663 | | |
| 416 | |
| Total operating expenses | |
| 793 | | |
| 544 | |
| | |
| | | |
| | |
| Income from operations | |
| 593 | | |
| 794 | |
| | |
| | | |
| | |
| Other income | |
| 17 | | |
| - | |
| Interest income, net | |
| 137 | | |
| 13 | |
| Net income before income tax | |
| 747 | | |
| 807 | |
| Income tax expense | |
| 359 | | |
| - | |
| Net income | |
$ | 388 | | |
$ | 807 | |
| | |
| | | |
| | |
| Net income per share - Basic | |
$ | 0.03 | | |
| - | |
| Weighted average shares outstanding - Basic | |
| 12,287 | | |
| - | |
| Net income per share - Diluted | |
$ | 0.03 | | |
| - | |
| Weighted average shares outstanding - Diluted | |
| 12,351 | | |
| - | |
Buda
Juice LLC
Statements
of Cash Flows
(Amounts
in Thousands)
| | |
Three Months Ended | |
| | |
March 31, 2026 | | |
March 31, 2025 | |
| Cash flows from operating activities | |
| | | |
| | |
| Net income | |
$ | 388 | | |
$ | 807 | |
| Adjustments to reconcile net income to net cash provided by operating activities: | |
| | | |
| | |
| Depreciation and amortization | |
| 57 | | |
| 87 | |
| Amortization of right to use asset | |
| 36 | | |
| 25 | |
| Deferred income taxes | |
| 182 | | |
| - | |
| | |
| | | |
| | |
| Changes in assets and liabilities: | |
| | | |
| | |
| Accounts receivable | |
| (108 | ) | |
| (143 | ) |
| Inventory | |
| (97 | ) | |
| 55 | |
| Prepaid expenses and other current assets | |
| 429 | | |
| (5 | ) |
| Accounts payable and other current liabilities | |
| 452 | | |
| 107 | |
| Payments on operating lease obligations | |
| (34 | ) | |
| (29 | ) |
| Net cash provided by operating activities | |
| 1,305 | | |
| 904 | |
| | |
| | | |
| | |
| Cash flows from investing activities | |
| | | |
| | |
| Capital spending of property and equipment | |
| (218 | ) | |
| (139 | ) |
| Net cash used for investing activities | |
| (218 | ) | |
| (139 | ) |
| | |
| | | |
| | |
| Cash flows from financing activities | |
| | | |
| | |
| Proceeds from initial public offering | |
| 23,000 | | |
| - | |
| Payments of underwriting discounts and offering costs | |
| (2,349 | ) | |
| - | |
| Redemption of common stock | |
| (3,750 | ) | |
| - | |
| Cash distributed to owners | |
| - | | |
| (1,438 | ) |
| Net cash provided by (used in) financing activities | |
| 16,901 | | |
| (1,438 | ) |
| | |
| | | |
| | |
| Net change in cash and cash equivalents | |
| 17,988 | | |
| (673 | ) |
| Cash and cash equivalents at beginning of year | |
| 1,840 | | |
| 1,889 | |
| Cash and cash equivalents at end of year | |
$ | 19,828 | | |
$ | 1,215 | |
| Supplemental disclosures of cash flow information: | |
| | | |
| | |
| Cash paid for interest | |
| - | | |
| - | |
| Cash paid for taxes | |
| - | | |
| - | |
Non-GAAP
Financial Measures
This
press release includes references to Adjusted EBITDA and free cash flow, which are non-GAAP financial measures. These non-GAAP measures
are provided as supplemental information to assist investors in evaluating the Company’s operating performance and liquidity. They
are not intended to be considered in isolation or as a substitute for, or superior to, financial measures prepared in accordance with
GAAP.
Adjusted
EBITDA is defined as net income before interest expense, income taxes, depreciation and amortization, and certain non-recurring or
non-cash items.
Free
cash flow is defined as net cash provided by operating activities less capital expenditures.